Description
Recombinant monoclonal antibody to Doc2b. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma N150/21.3.
Target
Doc2b
Target Alias Names
N150/21.3R, N150/21, Double C2-like domain-containing protein beta, Doc2-beta
Isotype/Mimetic
IgG1
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression